Table 2 Key clinical characteristics and histopathology of DICER1-associated sarcomas reported in the literaturea
Site of sarcoma | Number of cases | Age at diagnosisb median (range) | Genderc female (n) | Other DICER1-associated conditions | Diagnosisd (n) | Histopathologye | ||
|---|---|---|---|---|---|---|---|---|
Rhabdomyoblastic differentiation | Anaplasia | Chondroid/myxoid differentiation | ||||||
Number of cases with feature present/number of cases tested | ||||||||
Brain | 26 | 6 y (0–76) | 13 | CBME (1) LC (1) CN (1) | ERMS (1) DICER1-associated primitive intracranial sarcomae (1) Sarcoma/sarcoma NOS (19) PNET (1) Glioblastoma (1) Mesenchymal Chondrosarcoma (1) Malignant tumor NOS (2) | 21/24 | 17/20 | 18/24 |
Uterus | 15 | 40.5 y (27–92) | 15 | Thyroid nodule (1) LC (1) | ERMS (2) Adenosarcoma (10) Adenosarcoma with RMS differentiation (2) Carcinosarcoma (1) | 9/13 | 6/8 | 3/3 |
Uterine cervix | 13 | 15 y (8–53) | 13 | MNG (7) PTC (1) LC (2) PPB (2) SLCT (3) Bladder ERMS (1) STS (1) | ERMS (11) Adenosarcoma (1) Central PNET (1) Anaplastic sarcoma of the kidney (10) | 9/9 | 3/3 | 4/4 |
Kidney | 10 | 8.9 y (0.6–13) | 6 | TFA (1) TFC (1) PPB (1) CN (1) Bladder RMS (1) SLCT (1) | 10/10 | 10/10 | 9/9 | |
Ovary | 6 | 7.5 y (5–10) | 6 | MNG (1) CN (1) SLCT (1) | ERMS (1) DICER1-associated ovarian sarcomae (1) Undifferentiated sarcoma (1) Carcinosarcoma (2) Fibrosarcoma (1) ERMS (5) | 4/4 | 5/5 | 2/2 |
Bladder | 5 | 0.5 y (0.11–13) | 3 | CBME (1) TFA (1) PPB (2) ASK (1) SLCT (1) cERMS (1) | 5/5 | 1/1 | 1/1 | |
Soft tissue | 5 | 23 y (16 to <39) | 4 | MNG (1) PTC (1) cERMS (1) | ERMS (1) RMS (1) Leiomyosarcoma (1) Sarcoma (1) DICER1-associated metastatic peritoneal sarcomae (1) | 4/4 | 1/1 | 1/1 |
Thyroid | 1 | 45 y | 1 | n/a | Carcinosarcoma (1) | 1/1 | 1/1 | 1/1 |
Unknown | 5 | 14 y (14 to <20) | 1 | MNG (1) | ERMS (3) RMS (2) | 1/1 | 1/1 | n/a |
Total N | 62 (72%) | 42 | 86 | 64/71 (90.1%) | 45/50 (90%) | 39/45 (86.7) | ||